Literature DB >> 20495644

Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome.

George A Poultsides1, Richard D Schulick, Timothy M Pawlik.   

Abstract

An R0 margin width of 1 cm has traditionally been considered a prerequisite to minimize local recurrence and optimize survival following hepatic resection for metastatic colorectal cancer. However, recent data have called into question the prognostic importance of the '1-cm rule'. Specifically, several studies have noted that, although an R0 resection is important, the actual margin width may not be as critical. We provide a brief overview of the impact of an R1 vs. an R0 resection on local recurrence and overall survival. In addition, we specifically review the impact of margin width in patients who have undergone an R0 resection. Finally, we highlight those factors most associated with an increased likelihood of an R1 resection and provide recommendations for avoiding and dealing with microscopic carcinoma discovered intraoperatively at the cut parenchymal transection margin.

Entities:  

Mesh:

Year:  2010        PMID: 20495644      PMCID: PMC2814403          DOI: 10.1111/j.1477-2574.2009.00121.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  34 in total

1.  A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584.

Authors:  G Steele; R Bleday; R J Mayer; A Lindblad; N Petrelli; D Weaver
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

Review 2.  A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma.

Authors:  Annelore Altendorf-Hofmann; Johannes Scheele
Journal:  Surg Oncol Clin N Am       Date:  2003-01       Impact factor: 3.495

3.  Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Authors:  René Adam; Valérie Delvart; Gérard Pascal; Adrian Valeanu; Denis Castaing; Daniel Azoulay; Sylvie Giacchetti; Bernard Paule; Francis Kunstlinger; Odile Ghémard; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

4.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.

Authors:  K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

5.  Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).

Authors:  Felix G Fernandez; Jeffrey A Drebin; David C Linehan; Farrokh Dehdashti; Barry A Siegel; Steven M Strasberg
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

6.  Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection.

Authors:  Norihiro Kokudo; Yoshio Miki; Sachiko Sugai; Akio Yanagisawa; Yo Kato; Yoshihiro Sakamoto; Junji Yamamoto; Toshiharu Yamaguchi; Tetsuichiro Muto; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2002-07

7.  Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer.

Authors:  J Yamamoto; K Sugihara; T Kosuge; T Takayama; K Shimada; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

8.  Saline-linked surface radiofrequency ablation: factors affecting steam popping and depth of injury in the pig liver.

Authors:  Stefan A Topp; Michael McClurken; David Lipson; Gundumi A Upadhya; Jon H Ritter; David Linehan; Steven M Strasberg
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

9.  Determinants of survival in liver resection for colorectal secondaries.

Authors:  H Ekberg; K G Tranberg; R Andersson; C Lundstedt; I Hägerstrand; J Ranstam; S Bengmark
Journal:  Br J Surg       Date:  1986-09       Impact factor: 6.939

10.  Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy.

Authors:  Alexander A Parikh; Bernhard Gentner; Tsung-Teh Wu; Steven A Curley; Lee M Ellis; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  21 in total

1.  Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.

Authors:  Ryan M Thomas; Mark J Truty; Graciela M Nogueras-Gonzalez; Jason B Fleming; Jean-Nicolas Vauthey; Peter W T Pisters; Jeffrey E Lee; David C Rice; Wayne L Hofstetter; Robert A Wolff; Gauri R Varadhachary; Huamin Wang; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2012-05-30       Impact factor: 3.452

2.  Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.

Authors:  Christophe Laurent; Jean-Philippe Adam; Quentin Denost; Denis Smith; Jean Saric; Laurence Chiche
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

3.  R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.

Authors:  Luca Viganò; Guido Costa; Matteo Maria Cimino; Fabio Procopio; Matteo Donadon; Daniele Del Fabbro; Jacques Belghiti; Norihiro Kokudo; Masatoshi Makuuchi; Jean-Nicolas Vauthey; Guido Torzilli
Journal:  J Gastrointest Surg       Date:  2018-06-08       Impact factor: 3.452

Review 4.  Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens.

Authors:  Stéphanie Truant; Cédric Séquier; Emmanuelle Leteurtre; Emmanuel Boleslawski; Mehdi Elamrani; Guillemette Huet; Alain Duhamel; Mohamed Hebbar; François-René Pruvot
Journal:  HPB (Oxford)       Date:  2014-07-09       Impact factor: 3.647

5.  Margin Status is Still an Important Prognostic Factor in Hepatectomies for Colorectal Liver Metastases: A Propensity Score Matching Analysis.

Authors:  Riccardo Memeo; Vito de Blasi; Rene Adam; Diane Goéré; Tullio Piardi; Emilie Lermite; Olivier Turrini; Francis Navarro; Nicola de'Angelis; Antonio Sa Cunha; Patrick Pessaux
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

Review 6.  Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis.

Authors:  Wei Liu; Yi Sun; Lei Zhang; Bao-Cai Xing
Journal:  Int J Colorectal Dis       Date:  2015-07-23       Impact factor: 2.571

7.  Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer.

Authors:  Andrea Peloso; Eloisa Franchi; Maria C Canepa; Letizia Barbieri; Laura Briani; Jacopo Ferrario; Carolina Bianco; Pietro Quaretti; Silvia Brugnatelli; Paolo Dionigi; Marcello Maestri
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

8.  Liver resection for colorectal liver metastases with peri-operative chemotherapy: oncological results of R1 resections.

Authors:  Clarisse Eveno; Mehdi Karoui; Etienne Gayat; Alain Luciani; Marie-Luce Auriault; Michael D Kluger; Isabelle Baumgaertner; Laurence Baranes; Alexis Laurent; Claude Tayar; Daniel Azoulay; Daniel Cherqui
Journal:  HPB (Oxford)       Date:  2012-10-22       Impact factor: 3.647

9.  Hepatectomy for Colorectal Cancer Liver Metastases in the Era of Modern Preoperative Chemotherapy: Evaluation of Postoperative Complications.

Authors:  Kengo Fukuoka; Satoshi Nara; Yoshitaka Honma; Yoji Kishi; Minoru Esaki; Kazuaki Shimada
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

10.  Optimal timing of systemic therapy in resectable colorectal liver metastases.

Authors:  Chukwuemeka Ihemelandu; Edward A Levine; Mebea Aklilu; George Yacoub; Russell Howerton; Britt Bolemon; Matthew Graham; Greg Russell; Perry Shen
Journal:  Am Surg       Date:  2013-04       Impact factor: 0.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.